Responses of Human Colorectal Tumor Cells to Treatment With the Anti–Epidermal Growth Factor Receptor Monoclonal Antibody ICR62 Used Alone and in Combination With the EGFR Tyrosine Kinase Inhibitor Gefitinib
Cancer Research - United States
doi 10.1158/0008-5472.can-06-1000
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2006
Authors
Publisher
American Association for Cancer Research (AACR)